Changes in Metabolic Parameters in Patients with Diabetic Kidney Disease Depending on the Status of D3
- PMID: 35319388
- DOI: 10.2174/1574887117666220321152855
Changes in Metabolic Parameters in Patients with Diabetic Kidney Disease Depending on the Status of D3
Abstract
Background: Type 2 diabetes is a metabolic disease characterized by hyperglycemia as a result of insulin resistance and decreased insulin secretion. A relatively large number of patients with this type of diabetes have abdominal obesity, which also affects insulin resistance development. Chronic hyperglycemia can lead to damage and dysfunction of various organs, and a striking example is diabetic nephropathy. Diabetic nephropathy is a specific kind of kidney damage that occurs due to complications of diabetes and is accompanied by the formation of diffuse or nodular glomerulosclerosis, which can lead to terminal renal failure and requires immediate substitution through renal therapy or renal transplantation. Diabetic nephropathy is diagnosed with albuminuria and a decrease in the rate of glomerular filtration.
Methods: This review was based on a literature search for the most important evidence of vitamin D as a possible method of prevention for obesity, type 2 diabetes, and diabetic nephropathy. Collected published articles were summarized according to their overall themes.
Results: In this review, we considered vitamin D as a possible method of treatment for type 2 diabetes, as well as its complications, including diabetic nephropathy.
Conclusion: Studies show that vitamin D inhibits the renin-angiotensin-aldosterone system, resulting in improved renal function in diabetic nephropathy. Vitamin D also has antiinflammatory, antiproliferative, and anti-metastatic effects, which improve endothelial function.
Keywords: Vitamin D; diabetic nephropathy; hyperglycemia; metabolic changes; renin-angiotensin-aldosterone system; type 2 diabetes.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15896-901. doi: 10.1073/pnas.0803751105. Epub 2008 Oct 6. Proc Natl Acad Sci U S A. 2008. PMID: 18838678 Free PMC article.
-
A Strategic Investigation on Diabetic Nephropathy; Its Conceptual Model and clinical Manifestations: A Review.Curr Diabetes Rev. 2023;19(5):e260422204036. doi: 10.2174/1573399818666220426091238. Curr Diabetes Rev. 2023. PMID: 35993472 Review.
-
Nodular glomerulosclerosis mimicking diabetic nephropathy without overt diabetes mellitus.Clin Nephrol. 2005 Oct;64(4):300-4. doi: 10.5414/cnp64300. Clin Nephrol. 2005. PMID: 16240902
-
25-hydroxyvitamin D Deficiency and Predictive Factors in Patients with Diabetic Nephropathy in Type 2 Diabetes Mellitus.Egypt J Immunol. 2018 Jun;25(2):11-20. Egypt J Immunol. 2018. PMID: 30600944
-
Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:1-7. doi: 10.1055/s-0029-1211783. Exp Clin Endocrinol Diabetes. 1997. PMID: 9288531 Review.
Cited by
-
Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies.Int J Mol Sci. 2023 Aug 3;24(15):12378. doi: 10.3390/ijms241512378. Int J Mol Sci. 2023. PMID: 37569752 Free PMC article. Review.
References
-
- Falalyeyeva T.; Komisarenko I.; Yanchyshyn A.; Vitamin D in the prevention and treatment of type-2 diabetes and associated diseases: A critical view during COVID-19 time. Minerva Biotechnology and Biomolecular Research 2021,33(2),65-75 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical